The SU2C–Cancer Research UK (CRUK)–Lustgarten Foundation Pancreatic Cancer Dream Team is working to improve survival of pancreatic cancer patients, with a goal of at least doubling the one-year survival rate in advanced pancreatic cancer from 35% to more than 70%. The team also aims to maintain remission in patients who have responded to treatment, extending and enhancing the lives of people with this disease.